Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, Maryland.
Human Genetics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, Maryland.
JAMA Ophthalmol. 2014 Apr 1;132(4):478-83. doi: 10.1001/jamaophthalmol.2013.8001.
IMPORTANCE Several studies have found no temporal or demographic differences in the incidence of retinoblastoma except for age at diagnosis, whereas other studies have reported variations in incidence by sex and race/ethnicity. OBJECTIVE To examine updated US retinoblastoma incidence patterns by sex, age at diagnosis, laterality, race/ethnicity, and year of diagnosis. DESIGN, SETTING, AND PARTICIPANTS The Surveillance, Epidemiology, and End Results (SEER) databases were examined for retinoblastoma incidence patterns by demographic and tumor characteristics. We studied 721 children in SEER 18 registries, 659 in SEER 13 registries, and 675 in SEER 9 registries. MAIN OUTCOMES AND MEASURES Incidence rates, incidence rate ratios (IRRs), and annual percent changes in rates. RESULTS During 2000-2009 in SEER 18, there was a significant excess of total retinoblastoma among boys compared with girls (IRR, 1.18; 95% CI, 1.02 to 1.36), in contrast to earlier reports of a female predominance. Bilateral retinoblastoma among white Hispanic boys was significantly elevated relative to white non-Hispanic boys (IRR, 1.81; 95% CI, 1.22 to 2.79) and white Hispanic girls (IRR, 1.75; 95% CI, 1.11 to 2.91) because of less rapid decreases in bilateral rates since the 1990s among white Hispanic boys than among the other groups. Retinoblastoma rates among white non-Hispanics decreased significantly since 1992 among those younger than 1 year and since 1998 among those with bilateral disease. CONCLUSIONS AND RELEVANCE Although changes in the availability of prenatal screening practices for retinoblastoma may have contributed to these incidence patterns, further research is necessary to determine their actual effect on the changing incidence of retinoblastoma in the US population. In addition, consistent with other cancers, an excess of retinoblastoma diagnosed in boys suggests a potential effect of sex on cancer origin.
除了诊断时的年龄外,几项研究都没有发现视网膜母细胞瘤的发病时间或人口统计学差异,但其他研究报告了性别和种族/民族差异的发病率变化。
通过性别、诊断时的年龄、侧别、种族/民族和诊断年份来检查美国更新后的视网膜母细胞瘤发病模式。
设计、设置和参与者:通过人口统计学和肿瘤特征检查了监测、流行病学和最终结果 (SEER) 数据库中的视网膜母细胞瘤发病模式。我们研究了 SEER18 登记处的 721 名儿童、SEER13 登记处的 659 名儿童和 SEER9 登记处的 675 名儿童。
发病率、发病率比(IRR)和发病率的年变化百分比。
在 SEER18 中,2000-2009 年期间,男孩的总视网膜母细胞瘤发病率明显高于女孩(IRR,1.18;95%CI,1.02 至 1.36),而早期报告则显示女性占主导地位。与白人非西班牙裔男孩相比,白西班牙裔男孩的双侧视网膜母细胞瘤发病率明显升高(IRR,1.81;95%CI,1.22 至 2.79),与白西班牙裔女孩相比(IRR,1.75;95%CI,1.11 至 2.91),因为自 20 世纪 90 年代以来,白西班牙裔男孩的双侧发病率下降速度较慢。自 1992 年以来,白人非西班牙裔人群中年龄小于 1 岁的儿童的视网膜母细胞瘤发病率显著下降,自 1998 年以来,双侧疾病患者的发病率也显著下降。
尽管视网膜母细胞瘤产前筛查实践的可用性变化可能导致了这些发病模式,但需要进一步研究以确定其对美国人群中视网膜母细胞瘤发病率变化的实际影响。此外,与其他癌症一致,男孩中诊断出的视网膜母细胞瘤过多表明性别可能对癌症起源有潜在影响。